COMPOSITION FOR PREVENTING OR TREATING OXYGEN-INDUCED RETINOPATHY COMPRISING CAFFEIC ACID PHENETHYL ESTER

摘要

The present invention relates to a composition comprising caffeic acid phenethyl ester (CAPE) as an active ingredient for preventing or treating oxygen-induced retinopathy (OIR), which can be used as a pharmaceutical composition for treating oxygen-induced retinopathy and a food composition for alleviating oxygen-induced retinopathy, by reducing lesion in an avascular region and treating oxygen-induced retinopathy which is an animal model with neovascular retinopathy.